Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Anglo-American law (1)
- COVID-19 (1)
- COVID-19 vaccines (1)
- Chenglin Liu (1)
- Chinese patent law (1)
-
- Developing countries affordable vaccines (1)
- Document retrieval (1)
- Document search (1)
- Equilibrium (1)
- Equitable access (1)
- European Union (1)
- Excessive duty of care (1)
- Gary Liu (1)
- IP rights (1)
- India (1)
- Innovation (1)
- Intellectual property rights (1)
- Lifesaving medicines (1)
- Manufacturing enterprises (1)
- Medicines Patent Pool (MPP) (1)
- Negligence (1)
- Paxlovid (1)
- Pfizer (1)
- Pharmaceutical companies (1)
- Public health crisis (1)
- Reasonable Importer (1)
- Reasonable Manufacturer (1)
- Reasonable Person (1)
- Rights protection (1)
Articles 1 - 2 of 2
Full-Text Articles in Law
Beyond Compulsory Licensing: Pfizer Shares Its Covid-19 Medicines With The Patent Pool, Chenglin Liu
Beyond Compulsory Licensing: Pfizer Shares Its Covid-19 Medicines With The Patent Pool, Chenglin Liu
Faculty Articles
On March 15, 2022, the United States, European Union, India, and South Africa reached an agreement on the waiver of intellectual property rights (IP rights) for COVID-19 vaccines. The waiver agreement has rekindled the debate on the balance between IP rights protection and equitable access to medicines during a public health crisis. India, South Africa, and other developing countries maintain that a waiver was the only way to make vaccines affordable and accessible. Leading pharmaceutical companies argue that the waiver will stifle innovation and make lifesaving medicines less accessible. Both sides have seemingly overlooked Pfizer's voluntary agreement with the Medicines …
Reconstruction Of The Reasonable Person Standard Under Chinese Patent Law, Weihong Yao, Robert H. Hu
Reconstruction Of The Reasonable Person Standard Under Chinese Patent Law, Weihong Yao, Robert H. Hu
Faculty Articles
The standard of a Reasonable Person is the common basis for determining the duty of care of a patent infringer. Under the Chinese patent law, the standards for Reasonable Manufacturer and Reasonable Importer are among the highest standards in the world; such high Chinese standards impose an excessive duty of care for Chinese manufacturing enterprises, importers, and distributors, which hinder the development of those enterprises. We should reconstruct the Chinese patent law's Reasonable Person standard based on the characteristics of the patent system and the status quo of China's economic production. A Reasonable Manufacturer should be defined as an ordinary …